Author

M. Prudhomme

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 3 Approach:experimental assay· 3 Organism:human· 2 Assay:metagenomics· 2 Assay:proteomics· 2 Approach:statistical model· 2 Organism:bacteria (other)· 1 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

A.-L. Soulet· 2 shared C. H. G. JOHNSTON· 2 shared D. De Lemos· 2 shared P. Polard· 2 shared A. Vincent· 1 shared B. Panthu· 1 shared C. Machon· 1 shared F. Catez· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A.-L. Soulet

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Pneumococcal competence, a populational health sensor driving multilevel heterogeneity in response to antibiotics.

M. Prudhomme, C. H. G. JOHNSTON, A.-L. Soulet, D. De Lemos, N. Campo, P. Polard

This study reveals a populational QS mechanism in Streptococcus pneumoniae that drives antibiotic response heterogeneity through competence-induced bet-hedging.

bioRxiv · Nov 17, 2023 · PreprintMicrobiology

The alternative sigma factor σX mediates competence shut-off at the cell pole in Streptococcus pneumoniae.

C. H. G. Johnston, A.-L. Soulet, M. Berge, M. Prudhomme, D. De Lemos, P. Polard

This study identifies σX as a key regulator that spatially coordinates competence shut-off by anchoring DprA at the cell pole in Streptococcus pneumoniae.

bioRxiv · Jun 12, 2020Microbiology

Alteration of ribosome function upon 5-fluorouracil treatment favours cancer cell drug-tolerance

G. Therizols, Z. Bash-Imam, B. Panthu, C. Machon, A. Vincent, S. Nait Slimane, M. Garcia, F. Laforets, V. Marcel, J. Boubaker-Vitre, G. Souahlia, M.-A. Albaret, H. C. Mertani, M. Prudhomme, M. Bertrand, , J.-J. Diaz

This study shows that 5-FU treatment creates fluorinated ribosomes that selectively translate survival genes, promoting drug tolerance in cancer cells.

bioRxiv · Jun 4, 2020 · PreprintCancer Biology